BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19015401)

  • 1. Additive effects of obstructive sleep apnea and hypertension on early markers of carotid atherosclerosis.
    Drager LF; Bortolotto LA; Krieger EM; Lorenzi-Filho G
    Hypertension; 2009 Jan; 53(1):64-9. PubMed ID: 19015401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Atherosclerotic Inflammatory Pathways in Children with Obstructive Sleep Apnea.
    Smith DF; Schuler CL; Hossain MM; Huang G; McConnell K; Urbina EM; Amin RS
    J Pediatr; 2021 Dec; 239():168-174. PubMed ID: 34450122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early cardiovascular abnormalities in newly diagnosed obstructive sleep apnea.
    Baguet JP; Nadra M; Barone-Rochette G; Ormezzano O; Pierre H; Pépin JL
    Vasc Health Risk Manag; 2009; 5():1063-73. PubMed ID: 20057899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of CPAP on New Endothelial Dysfunction Marker, Endocan, in People With Obstructive Sleep Apnea.
    Altintas N; Mutlu LC; Akkoyun DC; Aydin M; Bilir B; Yilmaz A; Malhotra A
    Angiology; 2016 Apr; 67(4):364-74. PubMed ID: 26076702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cumulative association of obstructive sleep apnea severity and short sleep duration with the risk for hypertension.
    Priou P; Le Vaillant M; Meslier N; Paris A; Pigeanne T; Nguyen XL; Alizon C; Bizieux-Thaminy A; Leclair-Visonneau L; Humeau MP; Gagnadoux F;
    PLoS One; 2014; 9(12):e115666. PubMed ID: 25531468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukotriene B4 pathway activation and atherosclerosis in obstructive sleep apnea.
    Stanke-Labesque F; Pépin JL; de Jouvencel T; Arnaud C; Baguet JP; Petri MH; Tamisier R; Jourdil JF; Lévy P; Bäck M
    J Lipid Res; 2012 Sep; 53(9):1944-51. PubMed ID: 22761257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension in Cameroon associated with high likelihood of obstructive sleep apnea: a pilot study.
    Njamnshi AK; Mengnjo MK; Mbong EN; Kingue S; Fonsah JY; Njoh AA; Nfor LN; Ngarka L; Chokote SE; Ntone FE
    BMC Cardiovasc Disord; 2017 May; 17(1):112. PubMed ID: 28482815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Antihypertensive Medications on the Severity of Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis.
    Khurshid K; Yabes J; Weiss PM; Dharia S; Brown L; Unruh M; Jhamb M
    J Clin Sleep Med; 2016 Aug; 12(8):1143-51. PubMed ID: 27397663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent Presence of Obstructive Sleep Apnea and Elevated Homocysteine Levels Exacerbate the Development of Hypertension: A KoGES Six-year Follow-up Study.
    Kim J; Lee SK; Yoon DW; Shin C
    Sci Rep; 2018 Feb; 8(1):2665. PubMed ID: 29422547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian rhythms of risk factors and management in atherosclerotic and hypertensive vascular disease: Modern chronobiological perspectives of an ancient disease.
    Geng YJ; Smolensky MH; Sum-Ping O; Hermida R; Castriotta RJ
    Chronobiol Int; 2023 Jan; 40(1):33-62. PubMed ID: 35758140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of hypertension in high-risk ethnic minority with heart failure.
    Demede M; Pandey A; Innasimuthu L; Jean-Louis G; McFarlane SI; Ogedegbe G
    Int J Hypertens; 2011; 2011():417594. PubMed ID: 21747977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Metabolic Score for Insulin Resistance (METS-IR) Predicts Cardiovascular Disease and Its Subtypes in Patients with Hypertension and Obstructive Sleep Apnea.
    Yang W; Cai X; Hu J; Wen W; Mulalibieke H; Yao X; Yao L; Zhu Q; Hong J; Luo Q; Liu S; Li N
    Clin Epidemiol; 2023; 15():177-189. PubMed ID: 36815173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of the Coexistence of Somnipathy and Diabetes With the Risks of Cardiovascular Disease Events, Stroke, and All-Cause Mortality: A Systematic Review and Meta-analysis.
    Yang XH; Zhang BL; Cheng Y; Fu SK; Jin HM
    J Am Heart Assoc; 2022 Jul; 11(14):e024783. PubMed ID: 35861844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of sleep apnea and treatments on cardiovascular disease.
    Faria A; Macedo A; Castro C; Valle E; Lacerda R; Ayas N; Laher I
    Sleep Sci; 2022; 15(2):250-258. PubMed ID: 35755909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of obstructive sleep apnea on cerebrovascular compliance and cerebral small vessel disease.
    Lee WJ; Jung KH; Nam HW; Lee YS
    PLoS One; 2021; 16(11):e0259469. PubMed ID: 34767578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sleep duration and vascular inflammation using hybrid positron emission tomography/magnetic resonance imaging: results from the Multi-Ethnic Study of Atherosclerosis.
    Kundel V; Reid M; Fayad Z; Ayappa I; Mani V; Rueschman M; Redline S; Shea S; Shah N
    J Clin Sleep Med; 2021 Oct; 17(10):2009-2018. PubMed ID: 34606438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors for carotid and femoral artery intima-media thickness in a non-diabetic sleep clinic cohort.
    Lambeth C; Perri R; Lee S; Verma M; Campbell-Rogers N; Larcos G; Byth K; Kairaitis K; Amis T; Wheatley J
    PLoS One; 2021; 16(6):e0252569. PubMed ID: 34086802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brazilian Guidelines of Hypertension - 2020.
    Barroso WKS; Rodrigues CIS; Bortolotto LA; Mota-Gomes MA; Brandão AA; Feitosa ADM; Machado CA; Poli-de-Figueiredo CE; Amodeo C; Mion Júnior D; Barbosa ECD; Nobre F; Guimarães ICB; Vilela-Martin JF; Yugar-Toledo JC; Magalhães MEC; Neves MFT; Jardim PCBV; Miranda RD; Póvoa RMDS; Fuchs SC; Alessi A; Lucena AJG; Avezum A; Sousa ALL; Pio-Abreu A; Sposito AC; Pierin AMG; Paiva AMG; Spinelli ACS; Nogueira ADR; Dinamarco N; Eibel B; Forjaz CLM; Zanini CRO; Souza CB; Souza DDSM; Nilson EAF; Costa EFA; Freitas EV; Duarte EDR; Muxfeldt ES; Lima Júnior E; Campana EMG; Cesarino EJ; Marques F; Argenta F; Consolim-Colombo FM; Baptista FS; Almeida FA; Borelli FAO; Fuchs FD; Plavnik FL; Salles GF; Feitosa GS; Silva GVD; Guerra GM; Moreno Júnior H; Finimundi HC; Back IC; Oliveira Filho JB; Gemelli JR; Mill JG; Ribeiro JM; Lotaif LAD; Costa LSD; Magalhães LBNC; Drager LF; Martin LC; Scala LCN; Almeida MQ; Gowdak MMG; Klein MRST; Malachias MVB; Kuschnir MCC; Pinheiro ME; Borba MHE; Moreira Filho O; Passarelli Júnior O; Coelho OR; Vitorino PVO; Ribeiro Junior RM; Esporcatte R; Franco R; Pedrosa R; Mulinari RA; Paula RB; Okawa RTP; Rosa RF; Amaral SLD; Ferreira-Filho SR; Kaiser SE; Jardim TSV; Guimarães V; Koch VH; Oigman W; Nadruz W
    Arq Bras Cardiol; 2021 Mar; 116(3):516-658. PubMed ID: 33909761
    [No Abstract]   [Full Text] [Related]  

  • 19. Resveratrol Confers Vascular Protection by Suppressing TLR4/Syk/NLRP3 Signaling in Oxidized Low-Density Lipoprotein-Activated Platelets.
    Xue Y; Chen H; Zhang S; Bao L; Chen B; Gong H; Zhao Y; Qi R
    Oxid Med Cell Longev; 2021; 2021():8819231. PubMed ID: 33728029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting subclinical organ damage in obstructive sleep apnea: a narrative review.
    Cuspidi C; Tadic M; Gherbesi E; Sala C; Grassi G
    J Hum Hypertens; 2021 Jan; 35(1):26-36. PubMed ID: 32801297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.